eFFECTOR Therapeutics, Inc. (EFTRW) Financials
EFTRW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 20.2 million | 24.1 million |
2023-06-30 | 26.9 million | 24.3 million |
2023-03-31 | 21.9 million | 26.7 million |
2022-12-31 | 29.1 million | 25.2 million |
EFTRW Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.8 million | 1.1 million |
2023-06-30 | -8.6 million | 1.2 million |
2023-03-31 | -7.7 million | 1.2 million |
2022-12-31 | -6.8 million | 1.4 million |
EFTRW Net Income
No data available :(
EFTRW Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 17.8 million | - | 77000 |
2023-06-30 | 25.0 million | - | 94000 |
2023-03-31 | 19.0 million | - | 109000 |
2022-12-31 | 26.3 million | - | 120000 |
EFTRW Shares Outstanding
EFTRW Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 2000 | 5.4 million | 2.5 million | - |
2023-06-30 | 28000 | 4.9 million | 3.0 million | - |
2023-03-31 | 13000 | 6.6 million | 2.9 million | - |
2022-12-31 | 13000 | 6.6 million | 2.7 million | - |
EFTRW Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 26000 |
2023-06-30 | - | 27000 |
2023-03-31 | - | 28000 |
2022-12-31 | 675000 | 27000 |
EFTRW
Price: $0.03
52 week price:
Earnings Per Share: -0.91 USD
P/E Ratio: -0.12
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3053
Market Capitalization: 23.4 million